Revised estimate of the prevalence of multiple sclerosis in the United States.
about
New and emerging disease modifying therapies for multiple sclerosisDiagnosis of inflammatory demyelination in biopsy specimens: a practical approachReduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosisInfection as an Environmental Trigger of Multiple Sclerosis Disease ExacerbationDesign of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumaratePrecision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive AstrocytesNeuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depressionMultimodal Nonlinear Optical Microscopy and Applications to Central Nervous System Imaging.Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virusThe prevalence of multiple sclerosis in 3 US communitiesNuclear receptors and autoimmune disease: the potential of PPAR agonists to treat multiple sclerosis.Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.Pathologic heterogeneity persists in early active multiple sclerosis lesionsNeuroimmune interactions in a model of multiple sclerosis.Protease-activated receptor-1 activation by granzyme B causes neurotoxicity that is augmented by interleukin-1βImmune regulation of multiple sclerosis by CD8+ T cellsClinical and economic impact of a specialty care management program among patients with multiple sclerosis: a cohort study.Meningeal and cortical grey matter pathology in multiple sclerosis.Multiple sclerosis: empirical literature for the clinical health psychologist.The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service.Eye disorders in patients with multiple sclerosis: natural history and management.Disease modifying agents for multiple sclerosis.Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients.Toll-like receptors in multiple sclerosis.Functional electrical stimulation as a component of activity-based restorative therapy may preserve function in persons with multiple sclerosis.Endovascular therapy for chronic cerebrospinal venous insufficiency in multiple sclerosisPain affects depression through anxiety, fatigue, and sleep in multiple sclerosis.Task-specific and general cognitive effects in Chiari malformation type I.Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study.Social disruption induced priming of CNS inflammatory response to Theiler's virus is dependent upon stress induced IL-6 releaseStatins and their potential targets in multiple sclerosis therapy.Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis.Further evaluation of the Motivational Model of Pain Self-Management: coping with chronic pain in multiple sclerosis.Cost of multiple sclerosis by level of disability: a review of literature.Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes.High-affinity binding of remyelinating natural autoantibodies to myelin-mimicking lipid bilayers revealed by nanohole surface plasmon resonance.Using the international classification of functioning, disability and health to expand understanding of paralysis in the United States through improved surveillance.Perceptions of Health and Relationships to Disability Measures among People with Multiple Sclerosis.Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.Patterns and significance of concomitant central and peripheral inflammatory demyelination.
P2860
Q22242305-5955A6FC-160E-4A12-9978-EE1C3850A0ECQ24642895-662A59A9-27D7-4DC0-ABEA-1B7C65161EA2Q24647406-6A129DF3-D9CE-4D83-9347-80E2B6E3BACBQ26779416-FC275756-10AE-422C-AFB4-77554496F6EEQ27021147-10A19887-105D-4C1D-853A-6C062060FE47Q28078621-824DA23B-9B7A-42D0-8DAE-E8861D0BEBE3Q28220405-7631539D-26AA-4C45-9A63-B781B324A6C7Q33510696-40B8F2FC-8371-4799-A3F0-230478A85F9BQ33604807-402C5F9D-B157-45B0-B4A6-CB2FBCD9F7AAQ33610980-C896EFD9-F889-42EA-A602-2623F6F4C184Q33644094-1D24E76D-07FF-42CF-8F04-D0A31B6F031AQ33674644-19C8E9E3-16D2-4445-A572-DEF6B2C74FC4Q33804184-908A867A-2E81-4A6B-9B41-4DB7248B5124Q33821426-D02726A6-16AE-46A8-A85B-169BB0F7BBADQ33846630-2393463E-0FD8-46E9-B542-A7D0FB956DA7Q34017004-E00B070A-F003-4ED4-9CC3-244F93D4CE5CQ34072461-E971292B-4F4E-4836-B2D4-BAC4AB3DE3A1Q34187428-8C8663A9-5E63-42A1-88DC-6524EB24B687Q34187515-E50F3AC3-6A98-4661-87CC-AF0C5283C775Q34277165-B3B70A00-C343-4CCE-994A-489AD28CA77FQ34399820-FB038DFB-DD70-44DD-BDAB-5D85AB50B0EEQ34508451-FC53D111-A0B6-40C2-86C6-ED2F257E90A0Q34645439-74B111A0-B421-4F3F-AD58-329AF9B419B7Q34721972-A4DFF180-A5D8-4100-A13F-85737F76D8F6Q34947787-2B43AE4B-19ED-484D-BB18-49A646102DADQ35113791-22D5A768-CF93-4796-806D-90029B2B09CDQ35146090-97DBDDAF-CEBF-4A58-ACE0-AEC20AE6B925Q35149482-11A3B468-C57D-497D-BB82-490004E87665Q35399451-A1C48AAF-5D98-40C5-BD83-F913BAB27D1CQ35489039-AC2678E0-1678-4502-9C02-7A9E4F46B56CQ35537898-D83A64AD-9712-4A91-8849-634125FBD123Q35844748-8C3B3C38-D3E0-45AA-BD3A-0E0770914E55Q36021927-241EB0BB-6D67-482A-95B7-7D3D6FD7B155Q36081876-0877572B-E7F0-4A63-9FD2-855037357D7FQ36148455-1BF88E06-49F6-477D-B910-7F045ED64C2CQ36158112-96D46863-5F4C-4BBD-8D5B-2BA7DAAFA544Q36170159-E355D7E9-0295-44C6-8CD7-184EE85EA1D5Q36198176-D913E7E0-17C7-45E5-ABCC-523406E2F29BQ36327091-C0472666-D292-4E82-9739-C04D34F72AEFQ36474359-410E6566-4932-4E18-8A8E-BE1D08B87748
P2860
Revised estimate of the prevalence of multiple sclerosis in the United States.
description
1992 nî lūn-bûn
@nan
1992 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մարտին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Revised estimate of the prevalence of multiple sclerosis in the United States.
@ast
Revised estimate of the prevalence of multiple sclerosis in the United States.
@en
Revised estimate of the prevalence of multiple sclerosis in the United States.
@nl
type
label
Revised estimate of the prevalence of multiple sclerosis in the United States.
@ast
Revised estimate of the prevalence of multiple sclerosis in the United States.
@en
Revised estimate of the prevalence of multiple sclerosis in the United States.
@nl
prefLabel
Revised estimate of the prevalence of multiple sclerosis in the United States.
@ast
Revised estimate of the prevalence of multiple sclerosis in the United States.
@en
Revised estimate of the prevalence of multiple sclerosis in the United States.
@nl
P2093
P356
P1433
P1476
Revised estimate of the prevalence of multiple sclerosis in the United States.
@en
P2093
Anderson DW
Ellenberg JH
Leventhal CM
Reingold SC
Rodriguez M
Silberberg DH
P304
P356
10.1002/ANA.410310317
P577
1992-03-01T00:00:00Z